PMID int64 27.8M 36.2M | Title/Abstract stringlengths 7 10.7k | MeshTerms stringlengths 7 104 | SemanticTypes stringlengths 4 84 |
|---|---|---|---|
34,687,977 | quantif metabol equival met met repair questionnair valid studi patient high cardiovascular burden quantifi function capac core compon preoper cardiovascular risk assess lower metabol equival met associ higher morbiditymort non surgic surgic popul howev actual measur met preoper rare sought determin correl self report met use questionnair met reevalu periop cardiac risk met repair studi object measur met gold standard cardiopulmonari exercis test cpet | D005080;D017079 | T060;T201 |
34,687,976 | epidemiolog paediatr moder sever traumat brain injuri netherland traumat brain injuri tbi main caus death children around world last dutch epidemiolog studi describ incid year ago mechan injuri seem chang age child therefor import appreci differ age group abl lower impact childhood tbi understand current incid mechan injuri outcom necessari | D000070642 | T037 |
34,687,975 | contribut characterist two bifunct gh xylosidas l arabinofuranosidas differ structur xylan degrad paenibacillus physcomitrella strain xb xylan one major polymer hemicellulos constitu lignocellulos biomass effect util microorgan crucial econom product biofuel studi paenibacillus physcomitrella xb exhibit differ xylan degrad abil differ substrat corncob xylan ccx oat spelt xylan osx wheat flour arabinoxylan ax beech wood xylan bwx rt qpcr result show two gene pph pph belong glycosid hydrolas famili regul fold ccx xylos substrat specif assay purifi protein ppxyla pph ppxylb pph reveal exhibit xylosidas activ toward chromogen substrat p nitrophenyl xylopyranosid l arabinofuranosidas activ toward p nitrophenyl l arabinofuranosid indic bifunct test degrad characterist differ natur substrat found ppxyla ppxylb show similar degrad abil ccx osx enzym could hydrolyz xylohexaos xylobios complet xylos could hydrolyz bwx ax suggest main hydrolyz xylo oligosaccharid xylosidas activ analysi show display high ph stabil thermost xylosidas activ ppxyb exhibit wider ph temperatur rang higher ph temperatur stabil less influenc metal ion slower start respons ppxyla given predict structur like enzymat differ ppxyla ppxylb might relat extra c terminus domain ghc ppxylb could enhanc enzymat stabil restrict substrat metal ion access activ site ppxylb conclus ppxyla ppxylb xylosidas l arabinofuranosidas bifunct enzym might use xylan biomass convers especi hydrolysi xylo oligosaccharid xylos | D006026;D056507;D014990;D014995 | T116;T007;T121;T109;T126 |
34,687,974 | lipas immobil glutaraldehyd activ graphen oxidechitosancellulos acet electrospun nanofibr membran applic synthesi benzyl acet research lipas km immobil glutaraldehyd activ graphen oxidechitosancellulos acet nanofib gochitca nfs prepar electrospin method immobil lipas exhibit higher activ valu free lipas acid ph region enzym show c shift maximum temperatur activ result display vmax valu nfs lipas molmin gain molmin free lipas activ nfs lipas reserv min maintain c free lipas kept origin activ moreov enhanc lipas activ observ nfs lipas min incub c compar free enzym reusabl studi exhibit immobil lipas well kept origin activ cycl reus result display protein leak nfs lipas condit transesterif result indic free lipas exhibit convers level benzyl acet h incub besid immobil lipas show convers level condit result indic high perform free immobil lipas product benzyl acet applic perfum cosmet industri | D048271;D057139 | T121;T073;T109 |
34,687,973 | photo crosslink hyaluron acid hydrogel biomim extracellular matrix recapitul vivo featur breast cancer cell cell cultur wide util develop anti cancer drug explor mechan cancer tumorigenesi develop howev find obtain cultur often fail provid guidanc clinic tumor treatment sinc precis replic featur real tumor tumor model capabl recapitul nativ tumor microenviron prove promis altern techniqu herein construct breast tumor model novel hyaluron acid ha hydrogel prepar photocrosslink methacryl ha hydrogel use biomimet extracellular matrix incub mcf cell found methacryl degre great effect hydrogel microstructur mechan perform liquid absorb degrad abil optim hydrogel exhibit high porous morpholog high equilibrium swell ratio suitabl mechan properti hyaluronidas respons degrad behavior result demonstr ha hydrogel facilit mcf cell prolifer growth aggreg manner furthermor cultur mcf cell regul express vegf bfgf interleukin exhibit greater invas tumorigenesi capabl compar cultur cell therefor ha hydrogel reliabl substitut tumor model construct | D001943;D006820 | T191;T121;T109;T123;T122 |
34,687,972 | pollic treatment congenit sever hypoplasia aplasia thumb systemat review pollic index treatment choic sever hypoplasia aplasia thumb histor overview present systemat review procedur main step procedur report dieter buck gramcko still relev nowaday mani refin describ last decad differ surgeon address limit relat bone stock musculotendin structur skin incis howev consid complex procedur result literatur function esthet outcom still improv thank basic research pollic index rare done one demand surgic procedur hand surgeri | D006228;D019651 | T019;T061 |
34,687,971 | metabol syndrom risk gastrointestin cancer investig use larg scale molecular data gastrointestin cancer risk influenc presenc metabol syndrom met howev previous epidemiolog studi lack full serolog biomark data classif met interact met germlin cancer risk variant unknown | D000230;D006528;D004938;D000077277;D008113;D024821;D010190;D012004 | T191;T047 |
34,687,968 | chronic constip risk factor colorect cancer result nationwid case control studi prolong colon transit time may increas contact time potenti carcinogen stool colon mucosa nonetheless previous studi yield conflict result connect chronic constip risk colorect cancer crc examin associ chronic constip later crc | D015179 | T191 |
34,687,967 | factor associ chronic de novo post coronavirus diseas gastrointestin disord metropolitan us counti first coronavirus diseas covid pandem surg harsh impact medic underserv popul urban northeastern unit state sar cov virion infect gastrointestin gi tract gi symptom common acut infect post covid syndrom increas recogn import public health consider postinfecti disord gut brain interact dgbis former known function gastrointestin disord occur enter ill covid pandem anticip provok dgbi develop within rapid evolv post covid framework ill evalu factor associ dgbi like post covid gastrointestin disord pcgid hospit surround communiti compris predomin racialethn minor reduc socioeconom status | D000086382;D004066;D005767 | T047;T067 |
34,687,964 | transcrani direct current stimul combin alcohol cue inhibitori control train reduc risk earli alcohol relaps random placebo control clinic trial approxim half peopl alcohol use disord aud relaps alcohol reus next week withdraw treatment brain stimul cognit train repres recent form complementari intervent context aud | D065908 | T061 |
34,687,963 | target glioblastoma stem cell first step photodynam therapi glioblastoma one malign type brain cancer evid suggest within glioma small subpopul cell capac self renew call glioma stem cell cell could respons tumorigenesi chemo radioresist final recurr tumor fluoresc guid resect improv result treatment diseas prolong surviv patient month also clinic trial report potenti improv therapeut respons photodynam therapi thus far publish work show respons glioblastoma stem like cell photodynam therapi present brief review exclus comment therapeut approach elimin glioblastoma stem cell research public topic glioblastoma stem cell relat photodynam therapi hope review use provid overview known date topic promot generat new idea erad glioblastoma stem cell photodynam treatment | D001932;D005909;D010778 | T191;T061 |
34,687,962 | understand low mobil non communic diseas among peopl live ncds qualit studi hypertens urban south india low civil societi mobil ncd polici low middl incom countri lmic despit grow ncd burden exist research explain low mobil larg constraint inadequ fund capac organiz level explor issu perspect peopl live ncds ask lay understand hypertens may inform potenti mobil multisector polici action peopl live hypertens explor question develop theoret framework cast mobil function peopl recognit diseas import attribut ncd risk factor govern polici belief bear respons ncd prevent manag belief around efficaci multisector polici present find semi structur interview peopl live hypertens qualit studi chennai india themat analysi reveal respond dedic limit time resourc action around hypertens peopl live hypertens also strong intern respons develop manag condit focus primarili achiev lifestyl chang instead demand multisector polici action around hypertens respond recommend govern action focus measur enabl lifestyl chang increas awar health care capac express doubt efficaci govern polici find expand exist theori around mobil reveal peopl understand ill risk factor under driver well percept challeng ncd polici make present barrier mobil around multisector polici theori health social movement would benefit deeper integr individu perspect closer consider specif challeng live ncds given local context | D006973;D000073296 | T047 |
34,687,961 | medic manhood adhd diagnosi emerg alleg troublesom boy accra ghana although mental health diagnos treatment spread across globe medic research origin global north diagnosi treatment well institution articl examin earliest possibl emerg adhd diagnosi treatment context ghanaian boy transit toward manhood base ethnograph fieldwork among boy differ class background accra identifi interact troubl aris tricki transit manhood provid fertil inhibit context medic torn norm obedi autonomi strive societ achiev boy face obstacl road toward manhood yet medic demonstr boy adult use specif idiom ghanaian local languag twi describ issu around overact inattent refer medic categori instead wit emerg shift toward psycholog counsel potenti support global mental health action pentecost psycholog might constitut intermedi step toward medic troubl interact howev coloni stigma psychiatr label limit reach psycho medic institut ghana make medic unlik time possibl medic intersect interact problem inequ global spread psychiatri transit manhood medic label potenti adhd might shift blame famili diseas incipi introduct diagnosi treatment might engend creoliz notion adhd disrespect core problem | D001289;D062528 | T048;T054 |
34,687,960 | respiratori muscl train improv exercis toler respiratori muscl functionstructur post stroke short term systemat review meta analysi previous review relat effect respiratori muscl train rmt stroke tend focus one type train inspiratori expiratori muscl base result poor qualiti studi pedro score | D017079;D020521 | T047;T201 |
34,687,958 | cognit assess scale stroke patient casp multicentr valid studi mini mental state examin montreal cognit assess common use short screen batteri assess cognit impair stroke howev aphasia hemispati neglect may interfer result reason develop cognit assess scale stroke patient casp take condit consider previous demonstr superior scale term feasibl | D001037;D010468;D020521 | T048;T047 |
34,687,957 | cartilag oligomer matrix protein comp may better prognost marker ceacam correl colon cancer molecular subtyp tumor aggress overal surviv new tumor biomark need improv manag colon cancer cc second lead caus cancer relat death unit state carcinoembryon antigen cea translat protein carcinoembryon antigen relat cell adhes molecul ceacam gene use biomark cc cartilag oligomer matrix protein comp overexpress cc compar normal colon tissu studi aim evalu express comp diseas stage consensus molecular subtyp cms impact diseas outcom comparison ceacam | D003110 | T191 |
34,687,956 | past present futur therapeut strategi amyloid peptid alzheim diseas systemat review alzheim diseas ad preval neurodegen diseas age affect around million peopl worldwid treatment current avail etiolog ad still puzzl new drug develop clinic trial high failur rate urgent outlin integr multi target effect treatment ad need accumul amyloid peptid consid one fundament neuropatholog pillar diseas dyshomeostasi shown crucial role ad onset therefor mani amyloid target therapi investig systemat review recent investig follow review studi focus anti amyloid strategi summar analyz current clinic potenti combin anti therapi new develop earli detect biomark therapeut agent act earli function ad chang highlight review near term approv seem like sever drug act recent fda approv monoclon anti oligom antibodi aducanumab rais hope controversi conclud develop oligom epitop specif treatment implement multipl improv biomark risk predict method allow earli detect togeth therapi act factor hyperexcit earli ad could key slow global pandem | D000544;D019636 | T048;T047 |
34,687,955 | prevent bleed percutan biopsi small intestin submucosa hemostat plug percutan biopsi pbs gold standard diagnost procedur indic renal hepat disord nevertheless caus hemorrhag contraind coagulopath patient studi design fabric evalu small intestin submucosa sis plug reduc potenti ceas bleed decreas death risk percutan hepat renal biopsi healthi coagulopath vivo model first plug block capac determin increas diamet immers human blood capac induc clot surfac plug vivo perform evalu healthi porcin model show minim inflammatori reaction without side effect confirm histolog result day plug respons coagulopath model assess use heparin swine day reveal local microhemorrhag mild inflammatori respons without lesion surround tissu major advers event macroscop hemorrhag detect anim model furthermor assess plug efficaci reduc stop bleed use transplant discard human liver model n case mass blood lost lower plug transplant discard human liver biopsi compar control biopsi without plug bleed stop within three minut plug case non plug case demonstr feasibl make hemostat sis plug induc major inflammatori reaction effect reduc stop bleed pbs non coagulopath coagulopath vivo model transplant discard human liver model statement signific percutan biopsi pb gold standard diagnost procedur provok life threaten complic contraind patient coagulopath disord studi demonstr small intestin submucosa sis manufactur biocompat thrombogen plug insert commerci tru cut needl sheath devic take advantag collagen rich composit sis stop reduc bleed effect tradit pb indic could routin employ tradit biopsi increas safeti cost time reduc altern transjugular biopsi coagulopath patient | D006490;D008107 | T033;T047;T121 |
34,687,954 | nanomedicin b cell target therapi b cell play multipl role immun respons relat autoimmun diseas well differ type cancer strategi focus b cell target attract wide interest develop intens sever common mechan various b cell target therapi reli includ direct b cell deplet modul b cell antigen receptor bcr signal target b cell surviv factor target b cell cell costimul immun checkpoint blockad nanocarri use drug deliveri vehicl possess numer advantag low molecular weight drug reduc drug toxic enhanc blood circul time well augment target efficaci improv therapeut effect herein review common use target involv b cell target approach util various nanocarri b cell target deliveri vehicl statement signific b cell engag signific develop mani kind diseas util nanomedicin b cell deplet therapi rapid develop although numer studi focus b cell target alreadi done still various potenti receptor await investig review summar relev studi util nanotechnolog associ differ b cell deplet approach provid use tool select receptor agent andor nanocarri match specif diseas along uncov new target function map b cell grow number candid benefit nanoscal drug deliveri | D050997;D009369 | T191;T090 |
34,687,953 | surgic site infect prevent bundl intervent hip replac surgeri systemat review bundl shown improv patient outcom sever set surgic site infect ssis follow joint replac surgeri associ sever outcom aim determin effect non pathogen specif bundl intervent reduc ssis hip arthroplasti procedur | D019644;D013530 | T046;T061 |
34,687,951 | calcan osteotomi hindfoot deform calcan osteotomi extra articular procedur use conserv surgic treatment hindfoot deform static architectur dynam effect reorient tuberos action point digastr muscl format sural tricep plantar aponeurosi calcan osteotomi vari locat form displac categor tuberos osteotomi act talar posit cervic osteotomi act chopart joint line orient describ main calcan osteotomi use hindfoot deform talar varusvalgus valgus flatfoot midfoot abductusadductus case describ techniqu result respons difficulti deal medial osteotomi perform percutan limit skin complic easili associ cervic calcan osteotomi manag valgus flatfoot hintermann cervic adduct osteotomi provid excel angular correct conserv medial cortic hing lateralizingosteotomi perform medial approach enhanc translat capac prevent acut tarsal tunnel syndrom otherwis confront correct foot deform involv complex multi dimension multi tissu surgeri riski concern segment termin vascular present three techniqu need master usual associ tendon andor ligament reconstruct procedur tourniquet time limit level evid v expert opinion | D002111;D005413;D019651 | T190;T023;T019;T061 |
34,687,950 | critic shoulder angl acromion index correl size rotat cuff tear scapular morpholog extrins factor play role rotat cuff tear rct etiolog object studi evalu relationship critic shoulder angl csa acromion index ai partial bursal side full thick rct size rct | D000070636;D012785 | T023;T047;T037;T033;T030 |
34,687,949 | compound odontoma associ calcifi odontogen cyst case report systemat review object present studi comprehens evalu publish case compound odontoma associ calcifi odontogen cyst coacoc english literatur describ clinic imag therapeut variabl condit august electron search pubm medlin web scienc sciencedirect springer scopus databas carri elig criteria includ public enough inform confirm diagnosi furthermor present clinic case year old male patient occac treat enucl obtain favor function result total case report literatur met inclus exclus criteria includ analyz discuss mayor patient women n averag age year maxilla affect bone n maxillari anterior region area highest number case n main clinic present volum increas n asymptomat n choic treatment enucl n case recurr report n studi allow updat characterist occac give effect vision treat rare patholog associ made two condit complet differ | D018333;D009807;D009810 | T190;T191;T047 |
34,687,948 | aspir dental item case report literatur review propos manag algorithm aim present studi describ case screwdriv implant aspir remov flexibl bronchoscopi studi review current literatur author also propos airway manag algorithm case suspect foreign bodi aspir dental procedur review english languag literatur aspir object clinic dental practic perform bronchoscopi main method dental item remov total case literatur enrol studi aspir dental crown prosthes follow implant materi tooth main aspir item prevent better way avoid type complic earli diagnosi facilit remov foreign bodi bronchoscopi consid treatment choic remov foreign bodi aspir also regular profession train basic life support requir | D001999;D005547 | T072;T020;T037;T061;T060 |
34,687,947 | multivitaminminer dietari supplement young children fill critic nutrient gap near third young us children take multivitaminminer mvm dietari supplement yet unclear formul compar requir | D019587;D009751 | T032;T168;T061 |
34,687,946 | emerg depart staff percept care children mental health condit number children mental health mh condit present emerg depart ed increas studi aim gain insight live experi ed staff care children mh condit understand percept current ed resourc need optim care | D001523;D008603 | T048;T041 |
34,687,945 | function gadofulleren amelior impair glycolipid metabol type diabet mice soar global preval diabet make urgent explor new drug high efficaci safeti nanomateri deriv bioactiv agent emerg one promis candid biomed applic present studi investig anti diabet effect function gadofulleren gf use obes dbdb non obes mous model type diabet mellitus mkr mous type diabet mellitus tdm model mous model diabet phenotyp includ hyperglycemia impair glucos toler insulin sensit amelior two four week intraperiton administr gf gf lower blood glucos level dose depend manner import restor blood glucos level could persist ten day withdraw gf treatment hepat aktgskfoxo pathway shown main target gf rebalanc gluconeogenesi glycogen synthesi vivo vitro furthermor gf treatment signific reduc weight gain dbdb mice reduc hepat fat storag inhibit de novo lipogenesi mtorsksrebp pathway data provid compel evid support promis applic gf treatment tdm | D003921;D003924;D007333 | T047;T050;T046 |
34,687,944 | accept commit train veteran polytrauma random control trial protocol mild traumat brain injuri mtbi signatur wound veteran oper iraq afghanistan ie oifoefond veteran mtbi also experi stress base psychopatholog eg depress posttraumat stress disord chronic pain combin refer polytrauma result detriment long term effect social occup communiti reintegr studi compar efficaci one day accept commit train plus educ resourc support acter workshop one day activ control group er symptom distress social occup communiti reintegr also examin mediat moder treatment respons | D000086382;D009104;D014728 | T098;T047;T037;T067 |
34,687,943 | molecular respons mechan silkworm bombyx mori l toxic octyl methylimidazol chlorid base transcriptom analysi midgut silk gland previous studi silkworm larva use novel model assess biotox il show il could caus signific physiolog biochem chang midgut silk gland larva result death larva order investig toxic octyl methylimidazol chlorid c mim cl larva molecular level rna sequenc technolog use construct transcriptom profil midgut silk gland work result show lot differenti express gene deg effect screen bioinformat softwar base transcriptom data refer genom give detail deg deg obtain midgut silk gland larva expos c mim cl h respect relat control addit gene ontolog go analysi suggest deg could divid three categori ie biolog process cellular compon molecular function involv multipl organell function complex biolog process kyoto encyclopedia gene genom kegg analysi show deg enrich varieti pathway signal transduct apoptosi glycolysi peroxisom autophagi hippo signal pathway arginin prolin metabol result quantit real time pcr histopatholog observ indic molecular mechan larva c mim cl toxicolog may attribut cell apoptosi regul via mitochondri pathway death receptor initi pathway thus result provid use data explor toxic il insect molecular level | D012831 | T204 |
34,687,942 | contamin characterist sourc analysi health risk assess heavi metal soil shi river basin china base high densiti sampl explor contamin heavi metal shi river basin soil china high densiti sampl surfac soil conduct studi absolut princip compon score multipl linear regress model apc mlr use identifi sourc heavi metal soil quantifi amount method assess heavi metal includ fuzzi synthet evalu index health risk assess result show heavi metal relat rich southwest studi area level may affect natur sourc parent materi pollut caus human factor ignor primarili influenc traffic emiss process sourc contribut follow agricultur sourc pesticid fertil contribut risk assess indic studi area slight moder pollut heavi metal pose higher carcinogen health risk children adult ingest main way pollut enter bodi carcinogen risk children owe cr natur sourc merit studi carcinogen risk adult non carcinogen risk adult children accept level transport industri process sourc main caus non carcinogen risk result could provid refer reduc heavi metal pollut soil | D019216;D012989 | T131;T196 |
34,687,941 | semin plasma protein peptidyl arginin deaminas rrna adenin n methyltransferas kiaa link better motil post thaw stallion semin plasma play import role sperm physiolog semin plasma protein vehicul microvesicl carri rnas protein potenti role earli embryo develop addit protein present semin plasma particip redox regul energi metabol view fact hypothes differ protein composit semin plasma among stallion may help explain differ freez abil seen among three independ ejacul differ stallion vari breed frozen use standard protocol laboratori aliquot ejacul separ store c proteom analysi semen analysi perform use comput assist sperm analysi flow cytometri signific differ proteom composit semin plasma observ group stallion show better motil post thaw protein identifi differenti express stallion better motil post thaw also differenti express stallion differ percentag linear motil sperm post thaw protein midasin express stallion show high circular veloc post thaw semin plasma protein may play major role sperm function vehicul extracellular vesicl particip sperm physiolog bioinformat analysi identifi discrimin protein abl predict outcom cryopreserv identifi potenti new biomark assess ejacul qualiti | D012662 | T058;T031;T059 |
34,687,940 | mir b p inhibit chicken granulosa cell prolifer steroid hormon synthesi via target gdf microrna mirna nt rnas direct post transcript repress mrna target divers eukaryot lineag granulosa cell gcs earliest differenti follicular somat cell initi primordi follicl differenti growth close relat develop follicl research follicular develop most focus granular layer well hormon synthesi induc granulosa cell differenti follicular select studi evalu effect mir b p chicken granulosa cell includ granulosa cell prolifer steroid hormon synthesi elev express mir b p signific inhibit granulosa cell prolifer steroid hormon synthesi affect apoptosi furthermor observ forecast growth differenti factor gdf target gene mir b p mir b p regul express gdf overal studi demonstr mir b p regul prolifer steroid hormon synthesi chicken granulosa cell inhibit express gdf | D055429;D035683 | T116;T114;T123 |
34,687,939 | factor impact overal event free surviv follow post chimer antigen receptor cell consolid hematopoiet stem cell transplant hematopoiet stem cell transplant hsct may use consolid chimer antigen receptor car cell therapi induc remiss patient relapsedrefractori b cell acut lymphoblast leukemia b littl known factor impact overal surviv os event free surviv ef post car hematopoiet stem cell transplant hsct present studi primari object identifi factor associ os ef consolid hsct follow car induc complet remiss cr transplant nave patient secondari object includ evalu osef relaps free surviv cumul incid relaps patient proceed hsct stratifi first second hsct well toler hsct follow car induc remiss retrospect review children young adult enrol car cell trial nation cancer institut target cd cd cd clinicaltrialsgov identifi nct nct nct proceed direct hsct follow car cell therapi juli februari children young adult pre b went direct hsct follow car therapi patient proceed first hsct median follow month transplant nave patient heavili pretreat prior car cell therapi median line therapi rang signific prior immunotherapi exposur blinatumomab inotuzumab andor car cell therapi patient receiv cd cd construct twelv patient primari refractori diseas median time car cell infus hsct day day rang day median os follow first hsct month confid interv ci month estim ne median ef month ci month ne month os ci ci respect ef ci ci respect individu factor associ decreas os ef univari analys post car consolid hsct transplant nave patient includ prior line therapi reach nr versus month p nr versus month p prior blinatumomab therapi nr versus month p nr versus month p prior inotuzumab therapi nr versus month p month versus month p blast mm marrow pre car cell therapi nr versus month p nr versus month p primari refractori diseas associ improv osef post hsct nr versus month p nr versus month p extens prior therapi particular immunotherapi high diseas burden individu advers impact osef follow post car cell consolid hsct transplant nave patient owe primarili relaps despit hsct remain import treatment modal long term cure earlier implement hsct multipli relaps diseas incorpor post hsct risk mitig strategi patient identifi high risk post hsct relaps may improv outcom | D018380;D000076962 | T192;T129;T116;T061 |
34,687,937 | mitochondri iron sulfur cluster biogenesi neurolog disord iron sulfur cluster isc high conserv moieti embed numer crucial protein almost bacteria plant mammal isc biosynthesi critic cellular function pathway first character bacteria late subsequ year increas understand compon human defect isc pathway associ mani differ human diseas state friedreich ataxia iscu myopathi whilst disord variabl clinic featur involv neurolog phenotyp common biochem signatur condit lack isc caus defici target protein includ complex ii iii aconitas lipoic acid review focus disord isc biogenesi describ literatur date key clinic biochem neuroradiolog featur discuss provid refer point clinician diagnos manag patient therapi most support stage howev improv understand pathophysiolog condit could pave way diseas modifi therapi near futur | D020022 | T032 |
34,687,936 | adopt advanc microneurosurg technolog intern survey oper microscop adjunct technolog continu refin advanc microneurosurg care frequent advanc use unknown present studi assess intern adopt microneurosurg technolog discuss valu | D038622;D011795 | T057;T098;T064;T170;T081;T067;T078;T062 |
34,687,933 | demograph analysi financi hardship face brain tumor survivor quantit analysi financi hardship face patient brain tumor lack present studi sought conduct longitudin analysi respons nation health interview survey patient diagnos brain tumor character impact demograph factor financi hardship indic | D001932;D009369 | T191 |
34,687,932 | novel clinic insight spinal hemangioblastoma adult systemat review hemangioblastoma hbs well vascular benign central nervous system tumor third common primari spinal cord tumor astrocytomaependymoma occur sporad part autosom domin von hippel lindau diseas tumor often multipl prone relaps spinal hbs common locat cervic cord associ syrinx format owe locat growth trend may caus signific neurolog deficit impair qualiti life conduct systemat review understand better clinic insight spinal hb adult compar spinal hb versus posterior cranial fossa hb | D018325;D013120;D013595;D006623 | T191;T047 |
34,687,929 | safeti effect flexibl cervic implant preliminari short term clinic result sought determin safeti effect flexibl cervic implant level cervic segment | D055959;D007405;D013123;D059145 | T190;T047;T061 |
34,687,928 | effect thymus vulgari thymbra spicata essenti oil andor extract pectin edibl coat preserv slice bologna aim research determin effect pectin coat made essenti oil andor extract thymus vulgari thyme thymbra spicata thymbra preserv aerob packag slice bologna cold storag treatment made essenti oil result reduct log cfug salmonella typhimurium atcc also pectin coat made essenti oil treat slice bologna lowest total mesophil bacteria log cfug total lactic acid bacteria cfug comparison non treat bologna log cfug total mesophil bacteria log cfug lactic acid bacteria applic emuls signific p storag signific p effect ph valu | D000080122;D009822;D010368 | T123;T121;T073;T109 |
34,687,927 | develop preoper clinic risk assess tool postop complic hysterectomi develop preoper risk assess tool quantifi risk postop complic within day hysterectomi | D007044;D011183 | T046;T061 |
34,687,926 | genotyp mutat pattern macrolid resist gene mycoplasma pneumonia children pneumonia qingdao china studi assess incid resist mycoplasma pneumonia mp children qingdao china | D009177;D011019 | T007;T047 |
34,687,924 | comparison video stylet video laryngoscop endotrach intub adult cervic neck immobilis meta analysi randomis control trial efficaci video stylet versus video laryngoscop tracheal intub patient cervic spine immobilis known imped intub process remain unclear | D020704 | T074 |
34,687,923 | perfus index physic principl physiolog mean clinic implic anaesthesia critic care photoplethysmographi ppg extens use puls oximetri monitor anaesthesia periop intens care howev compon ppg signal employ purpos non invas haemodynam monitor perfus index pi deriv ppg signal repres ratio pulsatil non pulsatil light absorb reflect ppg signal pi determin complex interlink involv reflect interact peripher central haemodynam characterist vascular tone stroke volum recent sever studi shed light interest perform variabl especi assess region neuraxi block success haemodynam monitor anaesthesia periop intens care nevertheless review yet publish concern interest pi field narrat review expos first physiolog pathophysiolog determin pi mean measur valu well potenti limit second part exist data concern use pi differ clinic set oper theatr intens care unit emerg depart present discuss final perspect concern use pi mention aspect explor regard tool underlin | D000758;D000081282 | T061;T081 |
34,687,920 | ulnar collater ligament reconstruct javelin thrower analysi return play rate patient outcom although result ulnar collater ligament reconstruct uclr basebal player well document literatur replet regard outcom uclr javelin thrower | D001484;D000070637;D017885;D004551;D000070638 | T023;T073;T056;T061;T030 |
34,687,919 | factor correl optim tension arthroscop rotat cuff repair use grasper tension attach littl known optim tension arthroscop rotat cuff repair arcr studi aim identifi preoper intraop postop factor correl tension arcr determin optim intraop tension use grasper tension attach tension meter attach common arthroscop surgic grasper | D017006;D000070636 | T037;T047;T023;T033 |
34,687,918 | athlet primari glenohumer instabl demonstr lower rate bone loss recurr instabl fail prior stabil purpos studi compar preoper magnet reson arthrographi find patient underw glenohumer stabil histori primari instabl recurr instabl fail stabil | D056352;D007593;D012785 | T023;T098;T097;T033;T030 |
34,687,917 | risk factor degen symptomat rotat cuff tear case control studi despit consider public health burden rotat cuff tear consensus risk factor associ symptomat rotat cuff tear studi larg data sourc use identifi factor associ symptomat rotat cuff tear defin case rotat cuff tear verifi imag oper report control symptomat shoulder without rotat cuff tear verifi imag oper report | D000070636 | T033;T047;T037 |
34,687,916 | impact upper extrem injuri polytrauma patient level trauma center upper extrem injuri often lead long term problem function qualiti life patient howev much known effect polytrauma patient studi aim describ upper extrem injuri polytrauma patient compar self report disabl qualiti life polytrauma patient vs without upper extrem injuri | D001134;D009104 | T037 |
34,687,915 | prolactinoma hyperprolactinemia defin level serum prolactin standard upper limit normal rang common find clinic practic prolactinoma main patholog caus prolactinoma lead sign symptom hormon oversecret galactorrhea hypogonad well symptom mass effect includ visual impair headach intracrani hypertens diagnosi involv prolactin measur sellar imag sever pitfal involv evalu may difficult proper manag treatment medic major case consist dopamin agonist present high respons rate favor safeti profil major advers effect monitor consist cardiac valvulopathi impuls control disord treatment option includ surgeri radiotherapi temozolomid may use aggress malign carcinoma final pregnanc outcom similar general popul even dopamin agonist treatment maintain | D010911;D015175 | T191 |
34,687,914 | multipl symmetr multipl famili lipomatosi lipoma common soft tissu tumor malign case lipomatosi defin presenc multipl benign lipoma bodi without lipoatrophi impact qualiti life signific differ entiti describ symmetr multipl lipomatosi msl also call madelung diseas famili multipl lipomatosi fml msl occur preferenti men also women alcohol abus differ subtyp diseas classic affect upper bodi nuchal region buffalo hump appear metabol compon obes frequent contrast dercum diseas pain sao complic metabol syndrom alcohol abus includ cancer may associ screen fml littl describ literatur sinc brodi first report fml occur preferenti third decad equal women men autosom domin compon classic accept variabl penetr within famili associ naevi angioma polyneuropathi gastrointestin comorbid report interest contrast lipodystrophi disord patient show insulin sensit profil better understand under pathophysiolog mechan would open avenu therapeut research sinc treatment symptomat date | D000071070;D008069 | T191;T047 |
34,687,911 | pituitari incidentaloma pituitari incidentaloma pi lesion pituitari region discov fortuit imag reason unrel pituitari diseas rang small cyst larg invas adenoma world improv qualiti avail radiolog examin lead increas discoveri pi last four decad signific advanc made understand pi autopsi studi shown deceas individu harbour pi often non function microadenoma contrast modern patient seri show among pis come endocrinolog attent signific proport macroadenoma mani patient suffer asymptomat pauci symptomat endocrin ophthalmolog disturb adenoma empti sella rathk cleft cyst craniopharyngioma meningioma frequent type pis micro incidentaloma macro incidentaloma grow time case manag conserv mere surveil follow necessari patient macroadenoma uncertainti remain microadenoma extent endocrinolog work well necess durat follow visual endocrin anomali constitut common indic surgeri need surgeri yield better outcom pis symptomat pituitari lesion | D033162 | T033 |
34,687,910 | weight base insulin intraven insulin infus reduc rate rebound hyperglycemia transit subcutan insulin medic intens care unit hyperglycemia often occur transit intraven insulin infus ivii subcutan insulin weight base basal insulin initi earlier cours ivii medic intens care unit micu weight base basal bolus regimen ivii potenti improv post ivii glycem control hour | D006943;D007328 | T116;T047;T121;T125;T033 |
34,687,909 | effect navig programm manag symptom relat head neck radiotherapi studi aim determin effect navig programm manag symptom relat head neck cancer hnc radiotherapi | D006258;D011788 | T191;T078 |
34,687,908 | preoper versus postop chemoradiotherapi local advanc rectal cancer outcom surviv toxic sphincter preserv prognost factor studi aim compar preoper chemoradiotherapi crt postop crt regard surviv local control diseas control sphincter preserv toxic also prognost factor treatment local advanc rectal cancer | D059248;D012004 | T191;T061 |
34,687,906 | effect mechanosensit ion channel piezo prolifer osteogen differenti human dental follicl cell explor role mechanosensit ion channel piezo prolifer osteogen differenti human dental follicl cell hdfcs mechan provid basi use hdfcs achiev bone regener | D003795;D010012 | T023;T042 |
34,687,905 | enhanc recoveri surgeri era open transforamin lumbar interbodi fusion retrospect propens match cohort studi enhanc recoveri surgeri era protocol multidisciplinari multimod approach shown facilit recoveri physiolog function reduc postop pain complic rate length stay without advers affect readmiss rate design implement era protocol recent spine surgeri literatur primarili focus patient undergo minim invas lumbar surgeri howev convent open transforamin lumbar interbodi fusion tlif remain common procedur date studi assess era protocol patient popul | D000080482;D013123 | T061 |
34,687,904 | intestin obstruct secondari malform child mayer rokitanski kster hauser syndrom mayer rokitanski kster hauser mrkh syndrom congenit disord character underdevelop uterus vagina | D058489;D000013;D007415 | T047;T019 |
34,687,903 | retrospect comparison time cessat acut heavi menstrual bleed adolesc follow two dose regimen combin oral hormon therapi although multipl hormon treatment strategi effect decreas heavi menstrual bleed hmb adolesc studi compar relat effect hormon therapi basi dose | D000740;D008595 | T047;T046 |
34,687,902 | review surgic neovagina techniqu manag vagin strictur review current avail method surgic nonsurg neovagin creation addit focus situat requir vagin stretch replac augment manag vagin stenosi strictur | D019651;D014564 | T019;T061 |
34,687,901 | compartment camp signal cardiac ventricular myocyt activ differ receptor act generat common second messeng cyclic adenosin monophosph camp elicit distinct function respons cardiac myocyt select sequest camp activ discret intracellular microdomain consid essenti generat receptor specif respons process control aspect compartment camp signal howev complet clear year technolog innov provid critic breakthrough advanc understand mechan under camp compartment factor identifi includ local product camp differenti distribut receptor local breakdown second messeng target distribut phosphodiesteras enzym limit diffus camp protein kinas pka depend buffer physic restrict barrier aim review provid discuss current knowledg highlight gap still exist field camp compartment cardiac myocyt | D000242;D032383 | T025;T121;T114;T123 |
34,687,900 | reposit ivermectin covid treatment molecular mechan action sar cov replic ivermectin ivm fda approv macrocycl lacton compound tradit use treat parasit infest shown antivir potenti previous vitro studi current ivm commerci avail veterinari drug also appli human treat onchocerciasi river blind parasit worm infect strongyloidiasi roundwormnematod infect light recent pandem repurpos ivm combat sar cov acquir signific attent recent ivm proven effect numer silico molecular biolog experi infect mammalian cell human cohort studi one promis studi report mark reduct releas virion unreleas virion level upon administr ivm vero hslam cell ivm mode action centr around inhibit cytoplasm nuclear shuttl viral protein disrupt importin heterodim complex imp downregul stat therebi effect reduc cytokin storm furthermor abil ivm block activ site viral clpro protein disrupt import machineri viral replic attach review compil molecular evid date review antivir characterist exhibit ivm thereaft discuss ivm mechan highlight clinic advantag could potenti contribut toward disabl viral replic sar cov summari collect review recent effort suggest ivm prophylact effect would strong candid clinic trial treat sar cov | D058492 | T062;T061 |
34,687,899 | rod shape nintedanib nanocryst improv oral bioavail multipl intestin absorpt pathway nintedanib bibf biopharmaceut classif system ii bcs ii drug good therapeut effect treatment nonsmal cell lung cancer howev show poor oral bioavail due low dissolut intestin absorpt studi aim fabric rod shape nanocryst enhanc oral bioavail improv dissolut absorpt bibf intestin prescript screen bibf nanocryst bibf ncs particl size nm zeta potenti mv fabric antisolv precipit ultrasound approach stabil sodium carboxyl methyl cellulos cmc na bibf ncs exhibit rod shape morpholog transmiss electron microscopi tem result powder x ray diffract pxrd differenti scan calorimetri dsc show crystal form bibf bibf ncs alter bibf ncs remark improv satur solubl dissolut bibf compar bibf powder accord result situ singl pass intestin perfus spip bibf ncs show improv absorpt membran permeabl k p app valu jejunum min cmmin respect k p app valu bibf ncs reduc signific addit inhibitor colchicin chlorpromazin indomethacin demonstr bibf ncs could absorb endocytosi mediat caveola clathrin micropinocytosi intestin cell evalu result show bibf ncs could taken macrophag transport caco monolay vivo pharmacokinet result show bioavail bibf ncs fold higher bibf solut bibf sol oral administr longer max h vs h summari rod shape bibf ncs could signific improv oral bioavail multipl intestin absorpt pathway | D002289;D008175;D053758 | T191;T073 |
34,687,897 | physiolog properti composit structur profil porcin gastrointestin mucus gastrointestin mucus hydrogel line lumin side gastrointestin epithelium offer barrier protect pathogen lubric intralumin content barrier properti likewis affect nutrient drug need penetr mucus reach epithelium prior absorpt order assess potenti impact mucus drug absorpt need inform natur gastrointestin mucus today relev avail literatur main deriv rodent studi work use larger anim speci pig model character mucus throughout length gastrointestin tract first report physiolog properti physic appear ph water content composit protein lipid metabolit content structur profil rheolog gel network porcin gastrointestin mucus find allow direct comparison characterist mucus various segment util improv understand role mucus region depend drug absorpt addit present work expect contribut assess porcin model preclin speci drug develop process | D065569;D041981 | T022;T042 |
34,687,896 | effect safeti immun checkpoint inhibitor combin palliat radiotherapi advanc melanoma systemat review radiotherapi frequent ad immun checkpoint inhibitor ici treat melanoma sought describ efficaci combin ici palliat radiotherapi prt assess safeti focus immun relat advers event ira | D000082082;D008545 | T043;T129;T191;T121 |
34,687,895 | opioid use frequenc earli axial spondyloarthr finland pharmacoepidem regist studi evalu opioid use among incid axial spondyloarthr axspa patient compar general popul | D018501;D000089183;D025241 | T047;T121 |
34,687,894 | fdg pet predict long term outcom anti pd therapi metastat melanoma previous shown patient treat program cell death protein pd without ctla progress year complet metabol respons cmr includ two third patient partial respons pr report year outcom | D019788;D008545 | T130;T191;T109 |
34,687,891 | anticoagul therapi associ increas access relat wound infect hemodialysi access creation effect anticoagul therapi ac hemodialysi access patenc relat complic well defin patient long term chronic ac due under comorbid condit may particular suscept access relat bleed complic repetit cannul goal assess effect anticoagul therapi outcom access creation | D001166 | T061 |
34,687,890 | gender racial ethnic dispar index hospit oper symptomat carotid stenosi texa hospit recent literatur societ recommend support earli revascular symptomat carotid patient tradit six week period nonetheless time intervent vari wide among popul goal studi identifi factor influenc carotid revascular index hospit patient symptomat diseas | D006760 | T058 |
34,687,889 | chang anesthesia reduc periprocedur urinari retent evar enhanc recoveri surgeri era program provid streamlin approach expedi postop care high volum procedur endovascular aortic repair evar becom standard treatment abdomin aortic aneurysm implement earli recoveri program warrant postop urinari retent pour remain problem lend longer hospit stay patient discomfort aim demonstr util monitor anesthet care mac plus local anesthesia modal minim urinari retent follow evar | D000768;D000772;D057510 | T061 |
34,687,888 | predict factor surgic complic first year follow kidney transplant recent year increas use margin donor graft grow preval peripher arteri diseas recipi observ meanwhil open surgic techniqu kidney transplant chang aim studi analyz surgic complic occur first year kidney transplant determin potenti predict risk factor | D016030 | T061 |
34,687,887 | elev transposit method superfici basil vein achiev better patenc rate tunnel transposit compar tunnel transposit elev transposit method use superfici basil vein term complic patenc rate | D006435;D014654 | T042;T061 |
34,687,886 | outcom endovascular aneurysm repair adjunct stent endovascular aneurysm repair standard care abdomin aortic aneurysm repair howev data regard adjunct stent time endovascular aneurysm repair evar limit studi aim evalu outcom patient undergo evar without adjunct stent | D015607 | T074 |
34,687,885 | differ periop outcom carotid revascular white non white patient racial dispar carotid endarterectomi cea carotid arteri stent cas continu persist aim provid larg scale analysi racial dispar periop outcom carotid revascular nation repres cohort patient sub analys stratifi procedur type symptomat status | D016894;D057510;D054624;D044465 | T080;T098;T061 |
34,687,884 | molecular character chemotaxi assay cc motif chemokin ligand japanes sea bass lateolabrax japonicus cc motif chemokin ligand ccl key chemokin attract various type leukocyt activ periton macrophag howev inform ccl fish limit ccl gene ljccl identifi japanes sea bass lateolabrax japonicus show upregul multipl tissu vibrio harveyi infect recombin ljccl rljccl signific induc migrat monocytesmacrophag mom vitro vivo nt induc neutrophil lymphocyt addit rljccl induc migrat lipopolysaccharid stimul mom type knockdown japanes sea bass cc chemokin receptor ljccr express mom rna interfer inhibit ljccl induc chemotaxi rest type mom moreov administr ngg rljccl effect increas surviv v harveyi infect fish decreas bacteri load studi demonstr ljccl function mom chemoattract via ljccr japanes sea bass v harveyi | D001492;D005393;D014733;D014735 | T013;T047;T007 |
34,687,883 | hmga nile tilapia oreochromi niloticus involv immun respons bacteri infect high mobil group hmga import biolog function inhibit differenti red blood cell nerv cell promot prolifer metastasi cancer cell regul inflammatori reaction howev role hmga respons bacteri infect econom fish nile tilapia oreochromi niloticus remain unclear studi hmga homolog success identifi character nile tilapia hmga express model biolog effect bacteri infect analyz open read frame orf hmga bp length encod amino acid possess hmg domain high mobil group domain coil coil region result express model show hmga wide distribut immun relat tissu healthi tilapia upregul time depend manner challeng streptococcus agalactia meanwhil knock express hmga reduc inflammatori respons tilapia degre tissu damag caus agalactia moreov knock express hmga reduc bacteri load tilapia tissu challeng agalactia improv surviv rate collect result show hmga may relat immun respons nile tilapia bacteri infect | D023681;D005393;D013290;D017210 | T013;T047 |
34,687,882 | microrna facilit comprehens respons bathymodiolina mussel symbiot nonsymbiot bacteria stimul bathymodiolina mussel domin speci cold seep hydrotherm vent could harbor endosymbiont gill bacteriocyt howev mechan under symbiosi remain larg undisclos year present studi global express pattern immun relat gene mirna survey gigantida platifron bacteri challeng use enrich symbiot methan oxid bacteria mob nonsymbiot vibrio result multipl pattern recognit receptor found differenti express h h post bacteria challeng distinct cluster stimul dozen immun effector along signal transduc also modul simultan mob vibrio challeng total mirna identifi gill differenti express post mob nonsymbiot bacteria challeng varieti immun relat gene annot target gene aforesaid differenti express mirna result biolog process includ immun recognit lysosom activ bacteria engulf suggest dynam modul mirna either symbiot nonsymbiot bacteria challeng suggest g platifron mussel could maintain robust immun respons invad pathogen establish symbiosi chemosynthet bacteria orchestra immun relat gene mirna | D060086;D035683;D049879 | T070;T204;T114;T123 |
34,687,881 | transcriptom profil reveal differenti express immun relat gene gill hybrid yellow catfish tachysurus fulvidraco pseudobagrus vachellii hypox stress potenti nlr mediat immun respons fish gill primari organ respond sudden chang dissolv oxygen level aquat environ hypox stress impair normal function gill tissu howev littl known mechan respons yellow catfish gill hypox stress studi compar transcriptom physiolog chang gill tissu hybrid yellow catfish tachysurus fulvidraco pseudobagrus vachellii hypoxia treat group mgl control group mgl fish hypoxia treat group gill filament underw adapt chang number vacuol gill tissu increas exposur hypox condit h result increas anaerob metabol decreas antioxid immun capac gill tissu transcriptom analys reveal differenti express gene includ regul regul gene fish hypoxia treat control group function analys indic main pathway enrich differenti express gene immun respons follow energi metabol signal transduct hypox stress transcript level gene involv nod like receptor signal pathway initi increas rapid decreas time suggest nod like receptor mediat immun respons play essenti role hypoxia toler resist hybrid yellow catfish result provid novel insight immun relat gene pathway activ hypox stress reveal detail earli adapt immun respons defens mechan hypox stress | D002397 | T013 |
34,687,880 | rna form baker yeast cultur without lipopolysaccharid lps modul gene transcript intestin epitheli cell model rtgutgc rainbow trout oncorhynchus mykiss object studi evalu intestin rtgutgc cell line could suitabl research dietari ingredi function modul inflamm lipopolysaccharid lps induc stress rtgutgc cell cultur togeth rna baker yeast reach confluenc h cell grown either compet l cm nutrient depriv l dm rtgutgc cell expos lps rna baker yeast either alon combin cm dm cultur harvest follow lps challeng h h lps induc transcript interleukin il interleukin il toll like receptor tlr interferon regul factor irf nuclear factor nf one multidrug transport abcc glutamin synthas gls rtgutgc cell one sampl point h andor h post lps challeng rna baker yeast cultur alon cultur h h rtgutgc cell harvest respect lps sampl point induc transcript inf tnf ticamtrif induc lps addit rna baker yeast affect il tlr irf nf compar respons trigger lps rna baker yeast alon affect abcc gls transcript set lps rna baker yeast affect distinct also common gene transcript intestin cell line cultur rtgutgc cell dm ad combin lps rna baker yeast reduc il transcript compar cell grown cm h h post lps challeng also rtgutgc cell grown dm lps induc transcript abcc declin measur h post lps challeng possibl indic optim transcript il abbc rtgutgc cell cultur time requir access adequ nutrient stress condit rna baker yeast induc inf transcript rtgutgc cell regardless medium complet depriv nutrient howev cultur rtgutgc cell dm enrich rna baker yeast longer period time h h seem benefici inf transcript | D017686 | T013 |
34,687,879 | conserv divers ascidian cell molecul involv inflammatori reaction ciona robusta model ascidian marin invertebr chordat belong earliest branch tunicata chordat phylum therefor interest studi evolut immun system due known genom non coloni ciona robusta previous consid c intestinali type model speci studi inflammatori respons intern defens ascidian main reli hemocyt circul hemolymph pharynx hemocyt vivo challeng lps inject various granulocyt vacuol cell popul differenti produc releas inflammatori factor molecular biolog gene express studi reveal complex defens mechan involv differ inflammatori hemocyt furthermor clone procedur allow sequenc analys molecular studi disclos immun relat gene famili includ toll like receptor galectin c type lectin collectin interlectin pentraxin like peroxinectin complement factor like tnf like il like tgf like mif like gene prompt upregul inflammatori stimulus show time cours transcript similar domain sequenc similar phylogenet relationship vertebr counterpart shed light immun relat gene evolut select bioassay well bioinformat approach allow character antimicrobi peptid identif post transcript molecular mechan abl influenc dynam gene regul describ synthesi purpos articl explor topic hemocyt molecul relat intern defenc ascidian involv inflammatori reaction well discuss current futur studi option detail literatur review | D002938 | T204 |
34,687,878 | effect autochthon lactobacilli immunolog import molecul rainbow trout bacteri infect studi intestin primocultur nowaday aquacultur industri one fastest grow industri intens aquacultur negat impact fish health probiot bacteria often use due benefici effect health host ei decreas diseas outbreak immunomodulatori effect better util feed aim work studi influenc probiot bacteria immun respons trout intestin cell primocultur infect pathogen bacteria experi test effect pre treatment intestin cell autochthon strain lactobacillus plantarum r biocenol ccm follow infect serious salmonid pathogen aeromona salmonicida subsp salmonicida ccm yersinia ruckeri ccm test probiot strain reduc inflamm salmonicida infect decreas express pro inflammatori cytokin increas express anti inflammatori cytokin contrast infect ruckeri caus immunosuppress probiot strain stimul immun regul express proinflammatori cytokin suppress express anti inflammatori cytokin result prerequisit immunomodulatori potenti strain action must confirm subsequ vivo experi | D048409;D001424;D005393;D017686;D015009 | T007;T047;T013 |
34,687,877 | retin peripapillari vessel densiti increas recov covid children optic coher tomographi angiographi evalu retin vascular chang children recov coronavirus diseas covid use optic coher tomographi angiographi octa compar result age match healthi children | D000086382;D041623 | T047;T060;T067 |
34,687,876 | valid reliabl eye track visual acuiti assess children cortic visual impair cortic visual impair cvi lead caus pediatr visual impair develop countri current evid base treatment method visual assess captur multipl domain visual function may facilit evalu propos therapi develop eye track protocol evalu affer effer higher order visual paramet children cvi report valid reliabl assess visual acuiti | D000084542;D014787 | T073;T060 |
34,687,875 | ophthalm find mycoplasma induc rash mucos mirm distinct steven johnson syndrom identifi ophthalm manifest mycoplasma induc rash mucos mirm | D005076;D052016;D013262 | T047;T046;T184 |
34,687,874 | yardstick medic manag chronic rhinosinus chronic rhinosinus crs inflammatori condit paranas sinus defin classic symptom imag find endoscop find grow number emerg pharmacolog therapi evalu treat patient crs gain indic status unit state updat treatment guidelin publish unit state howev sinc document meant serv updat expert consensus document pharmacolog manag patient crs review avail data focus prospect clinic trial oral intranas corticosteroid nasal irrig biolog antibiot allergi immunotherapi crs without nasal polyposi includ specif therapi aspirin exacerb respiratori diseas associ crs allerg fungal crs multipl option treat crs clinician knowledg efficaci risk avail therapi allergist immunologist various therapi avail treat patient crs | D009298;D010256;D012220;D012852 | T023;T047;T030 |
34,687,872 | morbid among isra backpack travel tropic area travel tropic area may suscept ill injuri studi aim assess morbid among travel travel compar becam ill injur | D011818;D014195 | T047;T056 |
34,687,871 | delay cerebellar ataxia rare post malaria neurolog complic case report review literatur delay cerebellar ataxia dca rare post malari neurolog complic unknown pathomechan character self limit cours favor outcom report case dca follow uncompl plasmodium falciparum infect year old swiss travel return cameroon discuss case light publish literatur | D002524;D008288;D016778;D009422 | T033;T047;T184 |
34,687,870 | efficaci safeti repel market brazil bite aed aegypti aed albopictus systemat review dengu zika chikungunya virus repres serious public health problem evid avail efficaci repel commerci avail brazil systemat review assess efficaci safeti product contain repel commerci avail brazil protect bite aed aegypti aed albopictus | D000330;D007299;D007302;D000071244;D000071243 | T047;T005;T131;T204;T037 |
34,687,869 | effect benson progress muscl relax techniqu sleep qualiti coronari arteri bypass graft random control trial studi aim investig effect benson relax br progress muscl relax pmr techniqu sleep qualiti patient undergo coronari arteri bypass graft cabg surgeri | D001326;D012893 | T048;T047;T061 |
34,687,867 | new methodolog framework hazard detect model health inform technolog system adopt health inform technolog hit facilit effort increas qualiti effici health care servic decreas health care overhead simultan generat massiv amount digit inform store electron health record ehr howev due patient safeti issu result use hit system emerg need develop implement hazard detect tool identifi mitig risk patient paper present new methodolog framework develop hazard detect model demonstr capabl use us depart veteran affair va corpor data warehous data repositori va ehr overal purpos framework provid structur research communic research result one object decreas communic barrier interdisciplinari research stakehold provid structur detect hazard risk patient safeti introduc hit system error collect transmiss use process data ehr well potenti program configur error hit system nine stage framework creat compris program featur extract detector develop detector optim well support environ evalu detector model framework form foundat develop hazard detect tool foundat adapt method particular hit system | D063005;D008490 | T091;T170;T066 |
34,687,866 | absorpt transport distribut vitamin e homolog vitamin e eight differ natur occur form four tocopherol four tocotrienol tocopherol three asymmetr carbon natur tocopherol rrr tocopherol synthet tocopherol rac tocopherol util pharmaceut product food addit therefor determin distribut vitamin e bodi import regard absorpt transport vitamin e suggest pathway mediat three protein cd sr bi npcl well passiv diffus affect absorpt vitamin e vitamin e homolog main transport low densiti lipoprotein vldl tocopherol recogn tocopherol transfer protein liver howev also suggest chylomicron cms high densiti lipoprotein hdl involv transport vitamin e homolog small intestin section peripher tissu particular specul vitamin e homolog transport cms hdl enterocyt peripher tissu adipos tissu great affect distribut vitamin e homolog exclud tocopherol howev lipoprotein lipas affect incorpor vitamin e homolog contain lipoprotein peripher tissu unclear whether biodiscrimin vitamin e homolog incorpor peripher tissu lipoprotein interest question like futur research reveal individu vitamin e homolog incorpor peripher tissu especi brain adipos tissu skin | D014810;D024502 | T127;T121;T109 |
34,687,865 | jejun epitheli barrier disrupt trigger reactiv oxygen speci earli siv infect rhesus macaqu intestin epitheli barrier destruct occur earlier mucos immun dysfunct acut stage human immunodefici virus hiv simian immunodefici virus siv infect present howev caus compromis gastrointestin integr earli siv infect remain unknown current studi investig effect siv infect epitheli barrier integr explor oxid stress mediat dna damag apoptosi epitheli cell earli acut sivmac infect chines rhesus macaqu macaca mulatta result show sensit molecular marker small intestin barrier dysfunct ie intestin fatti acid bind protein ifabp signific increas plasma day post siv infect siv infect induc profound decreas express tight junction protein includ claudin claudin zonula occluden zo well signific increas activ form caspas level epitheli cell rna sequenc rna seq analysi suggest differenti express gene pre post siv infect jejuna enrich pathway involv cell redox homeostasi oxidoreductas activ mitochondria inde siv mediat increas reactiv oxygen speci ros epithelium macrophag well increas hydrogen peroxid h decreas glutathion gsh glutathion disulfid gssg antioxid defens observ siv infect jejuna addit accumul mitochondri dysfunct dna oxid damag led increas senesc associ galactosidas sa gal earli apoptosi intestin epitheli cell furthermor hiv tat protein induc epitheli monolay disrupt ht cell rescu antioxid n acetylcystein nac result indic mitochondri dysfunct oxid stress jejun epitheli cell primari contributor gut epitheli barrier disrupt earli siv infect rhesus macaqu | D016097;D015302 | T047;T005 |
34,687,864 | complex chemogenet toolkit differenti mdaao activ amino substrat subcellular target common approach investig oxid regul intracellular pathway add exogen h live cell tissu howev addit h cultur medium cell tissu approach accur replic intracellular redox mediat cell respons amino acid oxidas daao base chemogenet tool repres inform methodolog advanc permit generat h demand high spatiotempor resolut provid withdraw daao substrat amino acid much learn intracellular transport h studi use daao yet valuabl tool remain incomplet character mani cultur cell studi describ character detail featur new modifi variant daao term mdaao improv catalyt activ test mdaao function sever cultur cell line employ live cell imag techniqu imag experi show mdaao suitabl generat h hypox condit imag novel ultrasensit h sensor hyper moreov approach suitabl generat h revers concentr depend manner subcellular local furthermor show choic amino acid differenti affect mdaao depend intracellular h generat pair hydrogen sulfid h sensor hsgfp administr sulfur contain amino acid cystein cell express mdaao generat robust h signal also show chemogenet h generat differ cell type yield distinct hyper profil studi fulli character new mdaao novel chemogenet tool provid multiparametr approach cell manipul may open new line investig redox biochemist dissect role ros signal pathway high spatial tempor precis | D006861;D016877 | T130;T120;T121;T197 |
34,687,862 | conduct base dynam causal model mathemat review applic cross power spectral densiti dynam causal model dcm bayesian framework infer hidden latent neuron state base measur brain activ sinc introduct function magnet reson imag data dcm extend electrophysiolog data sever variant develop biophys motiv formul make model promis candid provid mechanist understand human brain dynam health diseas howev due complex relianc concept sever field fulli understand mathemat conceptu basi behind certain variant dcm challeng time solid theoret knowledg model crucial avoid pitfal applic model interpret result paper focus one advanc formul dcm ie conduct base dcm cross spectral densiti whose compon describ across multipl technic paper aim present articl provid access exposit mathemat background togeth illustr model behavior end includ step step deriv model equat point import aspect softwar implement model use simul provid intuit understand type respons generat role specif paramet play model furthermor code util simul made public avail alongsid manuscript allow reader easi hand experi conduct base dcm | D003198 | T066 |
34,687,861 | brain oscillatori correl visuomotor adapt learn sensorimotor adapt involv recalibr map motor command sensori feedback respons movement error although adapt oper within individu movement trial trial basi also undergo learn adapt respons improv cours mani trial brain oscillatori activ relat adapt learn process remain unclear main reason previous studi princip focus beta band confin outcom messag trial trial adapt provid wider understand adapt learn decod visuomotor task constant random perturb eeg record differ bandwidth brain region use multipl kernel learn approach differ experiment task intend separ trial trial adapt format new visuomotor map across trial found chang eeg power post movement period cours visuomotor constant rotat task particular increas theta power prefront region ii beta power supplementari motor area iii gamma power motor region classifi visuomotor task constant rotat versus random rotat abl relat power chang beta band main trial trial adapt error chang theta band would relat rather learn new map altogeth suggest tight relationship modul synchron low theta higher essenti beta frequenc oscil prefront sensorimotor region respect adapt learn | D004569;D000069550 | T034;T066;T060 |
34,687,860 | neural basi distractor resist visual work memori mainten visual work memori represent must protect interven irrelev visual input well known interfer resist challeng distractor match prioritis mnemon inform neural mechan remain poor understood identifi two top attent control process oppos effect distractor resist reveal earli select negat eeg respons match compar non match distractor magnitud negat associ behaviour distractor resist addit match distractor lead reduc post stimulus alpha power well increas fmri respons object select visual cortic area inferior frontal gyrus howev congruenc effect found post stimulus period alpha power inferior frontal gyrus fmri respons show posit associ distractor resist find suggest distractor interfer enhanc proactiv memori content guid select process diminish reactiv alloc top attent resourc protect memorandum represent within visual cortic area retain select mnemon code | D004569;D008279 | T170;T034;T059;T060 |
34,687,858 | causal decod individu cortic excit state brain respons stimul fluctuat rapid shift cortic excit state reflect oscil electroencephalogram eeg exampl amplitud motor evok potenti mep elicit transcrani magnet stimul tms motor cortex chang trial trial date individu estim cortic process lead excit fluctuat possibl propos data driven method deriv individu optim eeg classifi healthi human use supervis learn approach relat pre tms eeg activ dynam mep amplitud approach enabl consid multipl brain region frequenc band without defin priori whose compound phase pattern inform determin excit individu classifi lead increas classif accuraci cortic excit state compar oscil phase extract standard fix spatial filter result show use tms protocol excit fluctuat predomin oscil rang relev cortic area cluster around stimul motor cortex subject variabl relev power spectra phase cortic region novel decod method allow causal investig cortic excit state critic also individu therapeut brain stimul | D000069550 | T066 |
34,687,856 | cultur independ detect system bloodstream infect sepsi bloodstream infect associ signific morbid mortal earli effect antimicrobi therapi demonstr improv patient outcom tradit cultur base method howev sever limit hamper prompt diagnosi bloodstream infect includ long turnaround time limit sensit recent year advanc made develop sever technolog allow identif pathogen resist marker direct whole blood possibl repres promis altern convent cultur base method | D016470;D018805 | T047;T046 |
34,687,855 | azol echinocandin resist mechan genotyp candida tropicali japan cross boundari dissemin anim human transmiss c tropicali infect assess preval genet basi antifung resist mechan well genotyp candida tropicali clinic non clinic sourc japan | D001393;D041022 | T004;T109 |
34,687,854 | gray matter structur plastic patient basal ganglia germ cell tumor voxel base morphometri studi basal ganglia germ cell tumor bggcts rare intracrani germ cell tumor igct often present cognit impair | D001480;D066128;D009373;D009473 | T191;T023;T047;T043;T042;T024 |
34,687,853 | radiom machin learn pretreat assess prognost risk factor endometri cancer effect radiologist decis deep myometri invas evalu radiom machin learn ml classifi base multiparametr magnet reson imag mri pretreat assess endometri cancer ec risk factor examin effect radiologist interpret deep myometri invas dmi | D016889;D000069550 | T191;T066 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.